clinique envisage ltd
clinique envisage ltd Company Information
Company Number
08480967
Next Accounts
Dec 2025
Directors
Shareholders
ravindra kumar gupta
ambika chadha
Group Structure
View All
Industry
Other personal service activities n.e.c.
Registered Address
basement 32 woodstock grove, london, W12 8LE
Website
-clinique envisage ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINIQUE ENVISAGE LTD at £113.5k based on a Turnover of £232.1k and 0.49x industry multiple (adjusted for size and gross margin).
clinique envisage ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINIQUE ENVISAGE LTD at £167.3k based on an EBITDA of £52k and a 3.22x industry multiple (adjusted for size and gross margin).
clinique envisage ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINIQUE ENVISAGE LTD at £155.7k based on Net Assets of £79.4k and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Clinique Envisage Ltd Overview
Clinique Envisage Ltd is a live company located in london, W12 8LE with a Companies House number of 08480967. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in April 2013, it's largest shareholder is ravindra kumar gupta with a 50% stake. Clinique Envisage Ltd is a established, micro sized company, Pomanda has estimated its turnover at £232.1k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Clinique Envisage Ltd Health Check
Pomanda's financial health check has awarded Clinique Envisage Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
5 Weak
Size
annual sales of £232.1k, make it smaller than the average company (£840.3k)
- Clinique Envisage Ltd
£840.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 52%, show it is growing at a faster rate (8.2%)
- Clinique Envisage Ltd
8.2% - Industry AVG
Production
with a gross margin of 19.1%, this company has a higher cost of product (39.9%)
- Clinique Envisage Ltd
39.9% - Industry AVG
Profitability
an operating margin of 18% make it more profitable than the average company (5.7%)
- Clinique Envisage Ltd
5.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (14)
2 - Clinique Envisage Ltd
14 - Industry AVG
Pay Structure
on an average salary of £29k, the company has an equivalent pay structure (£29k)
- Clinique Envisage Ltd
£29k - Industry AVG
Efficiency
resulting in sales per employee of £116k, this is more efficient (£72.9k)
- Clinique Envisage Ltd
£72.9k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (27 days)
- Clinique Envisage Ltd
27 days - Industry AVG
Creditor Days
its suppliers are paid after 600 days, this is slower than average (37 days)
- Clinique Envisage Ltd
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Clinique Envisage Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (58 weeks)
0 weeks - Clinique Envisage Ltd
58 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 80.8%, this is a higher level of debt than the average (37.7%)
80.8% - Clinique Envisage Ltd
37.7% - Industry AVG
CLINIQUE ENVISAGE LTD financials
Clinique Envisage Ltd's latest turnover from March 2024 is estimated at £232.1 thousand and the company has net assets of £79.4 thousand. According to their latest financial statements, Clinique Envisage Ltd has 2 employees and maintains cash reserves of £5.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 3 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 408,193 | 417,748 | 427,692 | 36,395 | 19,330 | 27,954 | 39,622 | 48,913 | 9,142 | 11,427 | 14,283 |
| Intangible Assets | |||||||||||
| Investments & Other | |||||||||||
| Debtors (Due After 1 year) | |||||||||||
| Total Fixed Assets | 408,193 | 417,748 | 427,692 | 36,395 | 19,330 | 27,954 | 39,622 | 48,913 | 9,142 | 11,427 | 14,283 |
| Stock & work in progress | |||||||||||
| Trade Debtors | 162 | 7,765 | 704 | ||||||||
| Group Debtors | |||||||||||
| Misc Debtors | 77 | 8,089 | 12 | 1,000 | 41 | ||||||
| Cash | 5,166 | 17,253 | 452 | 33,698 | 4,450 | 2,494 | 2,631 | 1,502 | 1,495 | 543 | 615 |
| misc current assets | |||||||||||
| total current assets | 5,328 | 25,018 | 529 | 41,787 | 4,462 | 4,198 | 2,672 | 1,502 | 1,495 | 543 | 615 |
| total assets | 413,521 | 442,766 | 428,221 | 78,182 | 23,792 | 32,152 | 42,294 | 50,415 | 10,637 | 11,970 | 14,898 |
| Bank overdraft | |||||||||||
| Bank loan | |||||||||||
| Trade Creditors | 308,779 | 360,159 | 2,956 | 815 | |||||||
| Group/Directors Accounts | 365,874 | 30,824 | 30,464 | 28,959 | 32,898 | 38,304 | |||||
| other short term finances | |||||||||||
| hp & lease commitments | |||||||||||
| other current liabilities | 2,860 | 2,412 | 612 | 2,849 | 3,215 | 2,496 | 2,203 | ||||
| total current liabilities | 308,779 | 360,159 | 368,734 | 33,236 | 31,076 | 31,808 | 36,113 | 40,800 | 2,203 | 2,956 | 815 |
| loans | 45,000 | 50,000 | |||||||||
| hp & lease commitments | |||||||||||
| Accruals and Deferred Income | |||||||||||
| other liabilities | 25,367 | 35,059 | |||||||||
| provisions | |||||||||||
| total long term liabilities | 25,367 | 35,059 | 45,000 | 50,000 | |||||||
| total liabilities | 334,146 | 395,218 | 413,734 | 83,236 | 31,076 | 31,808 | 36,113 | 40,800 | 2,203 | 2,956 | 815 |
| net assets | 79,375 | 47,548 | 14,487 | -5,054 | -7,284 | 344 | 6,181 | 9,615 | 8,434 | 9,014 | 14,083 |
| total shareholders funds | 79,375 | 47,548 | 14,487 | -5,054 | -7,284 | 344 | 6,181 | 9,615 | 8,434 | 9,014 | 14,083 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 10,128 | 12,518 | 523 | 12,112 | 11,668 | 9,906 | 2,284 | 2,856 | 3,571 | ||
| Amortisation | |||||||||||
| Tax | |||||||||||
| Stock | |||||||||||
| Debtors | -7,603 | 7,688 | -8,012 | 8,077 | -1,692 | 1,663 | 41 | ||||
| Creditors | -51,380 | 360,159 | -2,956 | 2,141 | 815 | ||||||
| Accruals and Deferred Income | -2,860 | 448 | 1,800 | -2,237 | -366 | 719 | 293 | 2,203 | |||
| Deferred Taxes & Provisions | |||||||||||
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | |||||||||||
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | |||||||||||
| Group/Directors Accounts | -365,874 | 335,050 | 360 | 1,505 | -3,939 | -5,406 | 38,304 | ||||
| Other Short Term Loans | |||||||||||
| Long term loans | -45,000 | -5,000 | 50,000 | ||||||||
| Hire Purchase and Lease Commitments | |||||||||||
| other long term liabilities | -9,692 | 35,059 | |||||||||
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | -12,087 | 16,801 | -33,246 | 29,248 | 1,956 | -137 | 1,129 | 7 | 952 | -72 | 615 |
| overdraft | |||||||||||
| change in cash | -12,087 | 16,801 | -33,246 | 29,248 | 1,956 | -137 | 1,129 | 7 | 952 | -72 | 615 |
clinique envisage ltd Credit Report and Business Information
Clinique Envisage Ltd Competitor Analysis
Perform a competitor analysis for clinique envisage ltd by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in W12 area or any other competitors across 12 key performance metrics.
clinique envisage ltd Ownership
CLINIQUE ENVISAGE LTD group structure
Clinique Envisage Ltd has no subsidiary companies.
Ultimate parent company
CLINIQUE ENVISAGE LTD
08480967
clinique envisage ltd directors
Clinique Envisage Ltd currently has 1 director, Mrs Ambika Chadha serving since Apr 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Ambika Chadha | England | 45 years | Apr 2013 | - | Director |
P&L
March 2024turnover
232.1k
-15%
operating profit
41.8k
0%
gross margin
19.1%
-1.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
79.4k
+0.67%
total assets
413.5k
-0.07%
cash
5.2k
-0.7%
net assets
Total assets minus all liabilities
clinique envisage ltd company details
company number
08480967
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
April 2013
age
12
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
March 2024
previous names
N/A
accountant
JAFFER & CO
auditor
-
address
basement 32 woodstock grove, london, W12 8LE
Bank
-
Legal Advisor
-
clinique envisage ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to clinique envisage ltd.
clinique envisage ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CLINIQUE ENVISAGE LTD. This can take several minutes, an email will notify you when this has completed.
clinique envisage ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
